Advisory Council on Rare Diseases, Minn. Law 2019 c 65 s 1, 2021 1Sp c 2 art 1 s 4
Alzheimer's disease, see ALZHEIMER'S DISEASE
Amyotrophic lateral sclerosis
Caregiver support, Minn. Law 2022 c 42 s 1, 3
Research, Minn. Law 2022 c 42 s 2
Amyotrophic lateral sclerosis (ALS)
Caregiver support, Minn. Law 2024 c 125 art 2 s 8, 9, 2024 c 125 art 8 s 2, 2024 c 127 art 47 s 8, 9, 2024 c 127 art 53 s 2
Research, Minn. Law 2024 c 124 art 1 s 1, 2024 c 127 art 34 s 1
Anaphylaxis, epinephrine auto-injectors, school personnel authorized to administer, Minn. Law 2024 c 109 art 8 s 7
Chronic disease, studies, home care costs, Minn. Law 2016 c 179 s 14
COVID-19, see COVID-19
Genetic diseases, see HERITABLE AND CONGENITAL DISORDERS
Heart attack, Minn. Law 2016 c 88 s 1, 2
HIV, see HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Rare Disease Advisory Council, Minn. Law 2022 c 98 art 13 s 2, 12 to 14
Rare diseases
Definitions, Minn. Law 2023 c 70 art 2 s 25
Medical assistance coverage, Minn. Law 2023 c 70 art 1 s 26, 31, 32
Unrestricted access to services, retail pharmacy medications excluded, Minn. Law 2023 c 70 art 2 s 25
Rare Diseases Advisory Council, appropriations to, Minn. Law 2023 c 70 art 20 s 10
Terminal conditions, right to try investigational drugs, Minn. Law 2015 c 15